Tiantai Zhang Selected Research

Tiantai Zhang Research Topics

Disease

4	Neoplasms (Cancer) 05/2021 - 02/2019
4	Arthritis (Polyarthritis) 01/2018 - 03/2015
3	Inflammation (Inflammations) 04/2020 - 08/2011
3	Pain (Aches) 04/2015 - 02/2013
3	Atherosclerosis 09/2011 - 10/2006
2	Cognitive Dysfunction 04/2019 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 04/2019 - 01/2018
2	Rheumatoid Arthritis 03/2015 - 02/2013
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2021
1	Multiple Sclerosis 11/2021
1	Disease Progression 11/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 11/2021
1	Lymphoma (Lymphomas) 05/2021
1	Colitis 05/2021
1	Sepsis (Septicemia) 06/2020
1	Autoimmune Diseases (Autoimmune Disease) 04/2020
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 04/2020
1	Neuralgia (Stump Neuralgia) 01/2020
1	Hyperalgesia 01/2020
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2015
1	Experimental Arthritis 07/2014
1	Carcinoma (Carcinomatosis) 04/2011
1	Ventricular Remodeling 05/2010
1	Myocardial Infarction 05/2010
1	Parkinson Disease (Parkinson's Disease) 08/2008

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 12/2019 - 08/2008
3	Therapeutic UsesIBA 06/2020 - 07/2014
3	methyl salicylate (Linsal)FDA Link 01/2018 - 07/2014
2	Phosphotransferases (Kinase)IBA 01/2022 - 04/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2011
2	CytokinesIBA 04/2020 - 08/2011
2	LigandsIBA 04/2019 - 10/2006
2	Amyloid beta-PeptidesIBA 01/2018 - 01/2015
2	SalicylatesIBA 03/2015 - 02/2013
2	LipopolysaccharidesIBA 03/2015 - 08/2011
2	oxidized low density lipoproteinIBA 09/2011 - 10/2006
1	nintedanibIBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 11/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 11/2021
1	Pattern Recognition ReceptorsIBA 11/2021
1	InflammasomesIBA 11/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 05/2021
1	ibrutinibIBA 05/2021
1	triptolideIBA 05/2021
1	Janus KinasesIBA 04/2020
1	InterferonsIBA 04/2020
1	OxazoloneIBA 04/2020
1	tyrosine receptor (receptor, tyrosine)IBA 04/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	AlkaloidsIBA 01/2020
1	isotalatizidineIBA 01/2020
1	Dynorphins (Dynorphin)IBA 01/2020
1	Janus Kinase 2IBA 12/2019
1	Scopolamine (Hyoscine)FDA Link 04/2019
1	IsoflavonesIBA 04/2019
1	Tyrosine Kinase InhibitorsIBA 02/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2015
1	ethyl salicylateIBA 02/2013
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 09/2011
1	OxidesIBA 09/2011
1	Interleukin-6 (Interleukin 6)IBA 08/2011
1	Antineoplastic Agents (Antineoplastics)IBA 04/2011
1	Advanced Glycation End ProductsIBA 10/2008
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 10/2008
1	baicaleinIBA 08/2008
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 08/2008

Therapy/Procedure

2	Therapeutics 05/2021 - 05/2010
1	Punctures 06/2020
1	Ligation 06/2020
1	Intraperitoneal Injections 06/2020
1	Spinal Injections 01/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2015